The development of high dose melphalan and of autologous bone marrow transplantation in the treatment of multiple myeloma: Royal Marsden and St Bartholomew's hospital studies
- 1 April 1988
- journal article
- clinical trial
- Published by Wiley in Hematological Oncology
- Vol. 6 (2), 173-179
- https://doi.org/10.1002/hon.2900060218
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patientsBritish Journal of Cancer, 1988
- Multiple myeloma treated with high dose intravenous melphalanBritish Journal of Haematology, 1987
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983